Verition Fund Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
RG
Verition Fund Management's ZYME Position: Q2 2025 in Review
Verition Fund Management sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 114,156 shares — an estimated $1.36M sold.
Verition Fund Management first reported a position in ZYME in Q1 2023 and held it in 3 quarters. The position peaked at $1.36M in Q1 2025. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.
- Verition Fund Management reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
- Verition Fund Management sold 114,156 Zymeworks shares in Q2 2025, an estimated $1.36M.
- Verition Fund Management first reported a position in Zymeworks in Q1 2023 and held it in 3 quarters.
- Verition Fund Management's Zymeworks position peaked at $1.36M in Q1 2025.
- 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.
Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.